2Parkin D M, Bray F, Ferlay J, et al. Estimating the world cancer burden: Globocan 2000[J]. Int J Cancer, 2001,94(2): 153-156. 被引量：1
3Bruix J, Sherman M, Llovet J M, et al. Clinical management of hepatocellular carcinoma:Conclusions of the Barcelona-2000 EASL Conference[J]. J Hepatol,2001,35(2) :421-430. 被引量：1
4Bruix J, Llovet J M. Prognostic prediction and treatment strategy in hepatocellular carcinoma[J]. Hepatology, 2002,35 (3) : 519-524. 被引量：1
5Llovet J M,Fuster J,Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation[J]. Hepatology, 1999,30(4): 1434- 1440. 被引量：1
6Arii S, Yamaoka Y, Futagawa S, et al. Result of surgical and nonsurgical treatment for small-sized hepatollular carcinoma: A retrospective and nationwide survey in Japan[J]. Hepatology,2000,32(6) :1224-1229. 被引量：1
7Mazzaferro V,Regalia E,Doci R,et al. Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis[J]. N Engl J Med, 1996,334(11): 693-699. 被引量：1
8Sarasin F P, Majno P E, Llovet J M,et al. Living donor liver transplantation for early hepatocellular carcinoma:A life-expectancy and cost-effectiveness perspective[J]. Hepatology, 2001,33 (5) :1073-1079. 被引量：1
9Otto G, Heuschen U, Hofmann W J. et al. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis[J]. Ann Surg, 1998,227(3) :424-432. 被引量：1
10Vilana R,Bruix J,Bru C, et al. Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma[J]. Hepatology, 1992,16 (2) : 353-357. 被引量：1
